July highlights from the BLMs4BU project: We actively participated in the skin NTD-LABNET meeting in Madrid and launched a new sub-study in Côte d’Ivoire to explore Buruli ulcer patients’ journey and access barriers
Isra Cruz, member of the WHO Diagnostic Technical Advisory Group for NTDs and lead data manager of the BLMs4BU Consortium, hosted at the Instituto de Salud Carlos III (Madrid, Spain) a new meeting of the Skin NTD-LABNET (8-10 July).
Shedding light on the current and future on Buruli Ulcer and Leprosy treatment at the European Congress on Tropical Medicine and International Health, 2023
The European Congress on Tropical Medicine and International Health (ECTMIH) was held in Utrecht, Netherlands, on 20-23 November 2023, with more than 1000 attendants from all over the world.
The BLMs4BU Consortium contributes to the goals of the network of Buruli ulcer PCR laboratories (BU-LABNET) in the WHO African Region – Fifth Annual BU-LABNET Meeting
The BLMs4BU Consortium contributes to the mission of BU-LABNET by strengthening the laboratory capacity on PCR BU diagnosis in the WHO African region, as well as sharing knowledge and experiences between the member laboratories together with the BU National Programmes of these countries, striving to improve the quality of BU diagnosis.
Mid-term recruitment milestone achieve by the BLMs4BU Phase II project in Benin
Another milestone has been achieved by the BLMs4BU Consortium. The Phase II trial carried out in Benin has enrolled half of the number of patients needed for the study.
